ACTU
Actuate Therapeutics Inc.

116
Mkt Cap
$56.71M
Volume
6,956.00
52W High
$11.99
52W Low
$2.27
PE Ratio
-2.02
ACTU Fundamentals
Price
$2.29
Prev Close
$2.44
Open
$2.42
50D MA
$4.14
Beta
0.93
Avg. Volume
36,705.80
EPS (Annual)
-$1.40
P/B
5.19
Rev/Employee
$0.00
$147.24
Loading...
Loading...

About

Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
10

Frequently Asked Questions

What is Market Cap of Actuate Therapeutics Inc.?
What is the 52-week high for Actuate Therapeutics Inc.?
What is the 52-week low for Actuate Therapeutics Inc.?
What is Actuate Therapeutics Inc. stock price today?
What was Actuate Therapeutics Inc. stock price yesterday?
What is the PE ratio of Actuate Therapeutics Inc.?
What is the Price-to-Book ratio of Actuate Therapeutics Inc.?
What is the 50-day moving average of Actuate Therapeutics Inc.?
How many employees does Actuate Therapeutics Inc. have?

Latest ACTU News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.